Anantha Harijith
14PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Sep 12, 2024
Fingolimod, a sphingosine-1-phosphate receptor modulator, prevents neonatal bronchopulmonary dysplasia and subsequent airway remodeling in a murine model.Tara Sudhadevi, Akanksha Annadi, Prathima Basa
|Jun 24, 2024
Postnatal corticosteroid therapy in bronchopulmonary dysplasia - why animal studies disagree with clinical trials?Anantha Harijith, Thomas M Raffay, Rita M Ryan
|Jan 30, 2024
Sphingosine kinase 1-specific inhibitor PF543 reduces goblet cell metaplasia of bronchial epithelium in an acute asthma model.Tara Sudhadevi, Steven J Ackerman, Anjum Jafri
|Feb 15, 2022
The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia.Jaya M Thomas, Tara Sudhadevi, Prathima Basa
|Jun 27, 2021
Hyperoxia-induced S1P1 signaling reduced angiogenesis by suppression of TIE-2 leading to experimental bronchopulmonary dysplasia.Tara Sudhadevi, Anjum Jafri, Alison W Ha
Pageof 3